RedHill Biopharma Shareholders Approve All Resolutions
Ticker: RDHL · Form: 6-K · Filed: May 27, 2025 · CIK: 1553846
| Field | Detail |
|---|---|
| Company | Redhill Biopharma Ltd. (RDHL) |
| Form Type | 6-K |
| Filed Date | May 27, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, auditor-appointment, shareholder-meeting
TL;DR
RedHill Biopharma shareholders approved everything at the May 26th meeting, including auditors.
AI Summary
RedHill Biopharma Ltd. announced that at its adjourned Annual General Meeting of Shareholders on May 26, 2025, all proposed resolutions were approved. Key among these was the appointment of Kesselman & Kesselman as the Company's auditors for 2025 and beyond.
Why It Matters
Shareholder approval of auditor appointments is a routine but necessary step for corporate governance and financial reporting transparency.
Risk Assessment
Risk Level: low — This filing is a routine corporate update regarding shareholder meeting resolutions and auditor appointments, with no immediate financial or operational risks indicated.
Key Players & Entities
- RedHill Biopharma Ltd. (company) — Registrant
- Kesselman & Kesselman (company) — Appointed Auditors
- May 26, 2025 (date) — Date of Shareholder Meeting
FAQ
What was the outcome of the RedHill Biopharma Ltd. Annual General Meeting held on May 26, 2025?
All resolutions proposed to the shareholders at the adjourned Annual General Meeting on May 26, 2025, were duly approved.
Who has been appointed as the auditor for RedHill Biopharma Ltd. for 2025?
Kesselman & Kesselman, certified public accountants in Israel and a member of PricewaterhouseCoopers International Limited, has been appointed as the Company's auditors for the year 2025.
What is the address of RedHill Biopharma Ltd.'s principal executive offices?
The address of RedHill Biopharma Ltd.'s principal executive offices is 21 Ha'arba'a Street, Tel Aviv, 6473921, Israel.
Does RedHill Biopharma Ltd. file annual reports under Form 20-F or Form 40-F?
RedHill Biopharma Ltd. files annual reports under Form 20-F.
What is the Commission File Number for RedHill Biopharma Ltd.'s Form 6-K?
The Commission File Number for RedHill Biopharma Ltd.'s Form 6-K is 001-35773.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on May 27, 2025 regarding RedHill Biopharma Ltd. (RDHL).